Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Merck & Co Inc (MRK)  
$130.72 3.72 (2.93%) as of 4:30 Thu 4/25


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,530,000,000
Market Cap: 330.72(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $100.18 - $131.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  330
Guru Rank Value     : 3.8
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 3 409
Total Buy Value $0 $0 $341 $44,337
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 8
Total Shares Sold 409,617 455,521 845,213 4,068,540
Total Sell Value $51,615,837 $56,431,566 $101,562,509 $427,246,334
Total People Sold 8 9 10 12
Total Sell Transactions 9 11 22 48
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1211
  Page 9 of 49  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Frazier Kenneth C Executive Chair   •       •      –    2022-02-24 4 A $73.51 $8,783,563 D/D 119,488 706,283     -
   Deluca Richard R. EVP&Pres, Merck Animal Heallth   •       •      –    2022-02-24 4 A $73.51 $1,173,661 D/D 15,966 133,897     -
   Klobuchar Michael A EVP - Chief Strategy Officer   •       •      –    2022-02-24 4 A $73.51 $220,089 D/D 2,994 14,059     -
   Williams David Michael EVP,Chief Info&Digital Officer   •       •      –    2022-02-24 4 A $73.51 $122,027 D/D 1,660 8,604     -
   Chattopadhyay Sanat Exe V-P & Pres. MMD   •       •      –    2022-02-24 4 A $73.51 $1,458,144 D/D 19,836 112,981     -
   Zachary Jennifer EVP, General Counsel   •       •      –    2022-02-24 4 A $73.51 $1,354,054 D/D 18,420 53,419     -
   Li Dean Y Executive VP & President, MRL   •       •      –    2022-02-24 4 A $73.51 $222,221 D/D 3,023 15,462     -
   Williams David Michael EVP,Chief Info&Digital Officer   •       •      –    2022-02-10 4 D $76.53 $36,505 D/D (477) 6,944     -
   Williams David Michael EVP,Chief Info&Digital Officer   •       •      –    2022-02-10 4 OE $76.53 $91,989 D/D 1,202 7,421     -
   Frazier Kenneth C Executive Chair   •       •      –    2021-11-09 4 S $82.22 $54,611,362 D/D (663,881) 586,795 4%     
   Frazier Kenneth C Executive Chair   •       •      –    2021-11-09 4 OE $0.00 $0 D/D 663,881 1,250,676     -
   Litchfield Caroline EVP & CFO   •       •      –    2021-11-04 4 S $91.00 $1,668,503 D/D (18,335) 24,114 13%     
   Litchfield Caroline EVP & CFO   •       •      –    2021-11-04 4 OE $0.00 $0 D/D 22,683 42,449     -
   Deluca Richard R. EVP&Pres, Merck Animal Heallth   •       •      –    2021-11-04 4 S $90.40 $2,692,299 D/D (29,782) 116,930 13%     
   Deluca Richard R. EVP&Pres, Merck Animal Heallth   •       •      –    2021-11-04 4 OE $0.00 $0 D/D 29,782 146,712     -
   Karachun Rita A Sr. VP Fince-Global Controller   •       •      –    2021-11-03 4 S $88.45 $2,211,215 D/D (25,000) 35,799 11%     
   Karachun Rita A Sr. VP Fince-Global Controller   •       •      –    2021-11-03 4 OE $0.00 $0 D/D 25,000 60,799     -
   Gerberding Julie L. EVP, Chief Patient Officer   •       •      –    2021-11-01 4 S $87.91 $8,462,682 D/D (96,270) 39,162 10%     
   Gerberding Julie L. EVP, Chief Patient Officer   •       •      –    2021-11-01 4 OE $0.00 $0 D/D 96,270 135,432     -
   Clyburn Frank EVP & Pres ? Human Health   •       •      –    2021-11-01 4 S $87.87 $3,493,879 D/D (39,762) 97,095 10%     
   Clyburn Frank EVP & Pres ? Human Health   •       •      –    2021-11-01 4 OE $0.00 $0 D/D 39,762 136,857     -
   Mizell Steven EVP, Chief HR Officer   •       •      –    2021-10-30 4 D $88.05 $204,540 D/D (2,323) 25,573     -
   Mizell Steven EVP, Chief HR Officer   •       •      –    2021-10-30 4 OE $88.05 $415,156 D/D 4,715 27,896     -
   Clyburn Frank EVP & Pres ? Human Health   •       •      –    2021-10-30 4 D $88.05 $102,314 D/D (1,162) 97,095     -
   Clyburn Frank EVP & Pres ? Human Health   •       •      –    2021-10-30 4 OE $88.05 $207,622 D/D 2,358 98,257     -
  1211 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 49
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us